Streetbeat News

Insider Trading

SABS

Biotechnology Value Fund has disclosed a 5.3% ownership stake in SAB Biotherapeutics according to a recent 13G filing.

Portfolio Pulse from Charles Gross

December 04, 2023 | 9:40 pm

AMRN

Sarissa Capital has publicly stated that they believe Amarin Corporation's stock (AMRN) is significantly undervalued. Sarissa Capital, which is a long-term shareholder of Amarin, has been buying more shares at the current low prices. Details of their recent share purchases will be disclosed in an upcoming 13D filing.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:25 pm

BLMIF

EIS

A study by NYU and Columbia University researchers found unusual trading activity in Israeli stocks and ETFs, such as iShares MSCI Israel ETF (EIS) and Bank Leumi (BLMIF), before the Oct. 7 Hamas attacks. There was a surge in short selling and a sharp increase in put options, suggesting possible foreknowledge of the attacks. The study raises ethical and legal concerns and calls for regulatory review.

Portfolio Pulse from Piero Cingari

December 04, 2023 | 6:29 pm

DRTTF

QNCX

RDW

VWE

Insiders at four companies have made notable purchases of their own company's penny stocks. Vintage Wine Estates Director Timothy Proctor bought shares at an average price of $0.57, after the company reported a wider-than-expected quarterly loss. Redwire's Chief Accounting Officer Chris Edmunds acquired shares at $2.55 each following better-than-expected quarterly sales. 22NW GP, Inc., a 10% owner of DIRTT Environmental Solutions, invested around $2.29 million in shares at $0.51 each after the company reported a revenue increase. Quince Therapeutics Director David Lamond bought shares at $0.94 each after the company completed an acquisition. These transactions may signal insider confidence and are worth considering for investors interested in penny stocks.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 2:12 pm

AAPL

META

NVDA

Insiders at Apple, Meta Platforms, NVIDIA, and Electronic Arts have recently sold shares of their respective companies. Apple's Principal Accounting Officer sold shares amid news of ending a credit card partnership with Goldman Sachs. Meta's COO sold shares as the company faces a new complaint with the Austrian data protection authority. NVIDIA's EVP of Operations sold shares while the CEO discussed U.S. chip manufacturing dependency. EA's CFO sold shares following an earnings report that beat estimates.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 1:00 pm

AREN

Bryant R. Riley has sold the majority of its stake in The Arena Group (AREN) to Arena, as reported in a 13D/A filing.

Portfolio Pulse from Charles Gross

December 04, 2023 | 12:21 pm

HHH

PLSE

WEST

Insider purchases at Empire Petroleum, Pulse Biosciences, Howard Hughes Holdings, and Westrock Coffee indicate confidence in these companies. Empire Petroleum saw a significant buy from Energy Evolution Master Fund Ltd, while Pulse Biosciences, Howard Hughes Holdings, and Westrock Coffee had purchases by directors. These transactions suggest potential growth or undervaluation, but should not be the sole basis for investment decisions.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 11:42 am

JNJ

According to the Wall Street Journal, Johnson & Johnson is considering CFO Joseph Wolk and Executive Vice President Jennifer Taubert as potential successors to current CEO Joaquin Duato upon his departure.

Portfolio Pulse from Charles Gross

December 04, 2023 | 10:35 am

CRM

NVDA

Insiders at NVIDIA, Home Depot, Zoom Video Communications, and Salesforce have recently sold shares of their companies. NVIDIA Director Dawn E Hudson sold 11,000 shares, Home Depot EVP William Bastek sold 1,612 shares, Zoom Video Director Santiago Subotovsky sold 2,067 shares, and Salesforce Chair and CEO Marc Benioff sold 15,000 shares. These sales could indicate various things, including personal financial management or a lack of confidence in the company's future prospects. However, insider sales are not the sole indicator for investment decisions.

Portfolio Pulse from Lisa Levin

December 01, 2023 | 3:25 pm

SABS

VRME

Insiders at four companies have recently made notable purchases of their own company's stock, signaling potential confidence in their respective companies' futures. SAB Biotherapeutics' Executive Chairman acquired 11,000 shares, following the announcement of dosing trial participants in Australia. Earth Science Tech's CEO bought 230,000 shares after the company reported a net profit for its fiscal second quarter. Butler National's 10% owner purchased 25,272 shares, subsequent to FAA approval for Avcon Industries' modifications in King Air Model B300 Airplanes. VerifyMe's Director acquired 1,800 shares after the company posted upbeat quarterly results. These transactions may influence investors' perspectives on these penny stocks.

Portfolio Pulse from Lisa Levin

December 01, 2023 | 3:23 pm